In today’s NewsFlash Roundup, Abiomed implants an artificial heart, EMC implants itself in Cambridge, and Big Blue implants social networking in its LotusLive software.
- Nanotech researcher Mirkin named 2009 Lemelson-MIT winner
- Allot Communications plants North American HQ in Woburn
- Cerulean Pharma, Calando sign RNAi licensing deal
- NMT Medical names Richard Davis to board
- Abiomed succeeds in artificial heart implant
- EMC to open Cambridge lab, launch MIT sponsorship deal
- IBM adds Lotus social networking to SaaS
- Sentillion teams with Microsoft on Amalga
Posted by Brendan Lynch
Tags: Allot Communications, Amalga, Calando, Cerulean, Chad Mirkin, IBM, Lemelson-MIT, Lemelson-MIT Prize, Lotus, Microsoft, MIT, NMT Medical, Northwestern University, Richard Davis, Sentillion
RSS Feeds
